Postpartum depression symptoms: A case-control study on monoaminergic functional polymorphisms and environmental stressors

Psychiatric Genetics

Volumn 21, Issue 1, 2011, Pages 19-28

  Comasco, Erika ^a,d   Sylvén, Sara M ^b   Papadopoulos, Fotios C ^c   Sundström Poromaa, Inger ^b   Oreland, Lars ^a   Skalkidou, Alkistis ^b  

^a Departments of Neuroscience Pharmacology   (United States)

^b Women's and Children's Health ^*  (United States)

^c UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^d UPPSALA UNIVERSITY   (Sweden)

Author keywords

catechol O methyltransferase; Edinburgh Postnatal Depression Scale; environment; gene; monoamine oxidase A; monoamines; postpartum depression; serotonin transporter; stressful life events

Indexed keywords

AMINE OXIDASE (FLAVIN CONTAINING) ISOENZYME A; CATECHOL METHYLTRANSFERASE; SEROTONIN TRANSPORTER;

ARTICLE; CASE CONTROL STUDY; EDINBURGH POSTNATAL DEPRESSION SCALE; ENVIRONMENTAL FACTOR; FEMALE; GENE INTERACTION; GENETIC VARIABILITY; GENOTYPE; HUMAN; LIFE EVENT; MAJOR CLINICAL STUDY; MONOAMINERGIC SYSTEM; MOOD DISORDER; POPULATION RESEARCH; PRIORITY JOURNAL; PUERPERAL DEPRESSION; RISK FACTOR; SWEDEN; VARIABLE NUMBER OF TANDEM REPEAT;

ADULT; CASE-CONTROL STUDIES; CATECHOL O-METHYLTRANSFERASE; CHI-SQUARE DISTRIBUTION; DEPRESSION, POSTPARTUM; ENVIRONMENT; FEMALE; GENOTYPE; HUMANS; MIDDLE AGED; MINISATELLITE REPEATS; MODELS, GENETIC; MONOAMINE OXIDASE; MULTIVARIATE ANALYSIS; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; STRESS, PHYSIOLOGICAL; YOUNG ADULT;

EID: 78650797978     PISSN: 09558829     EISSN: None     Source Type: Journal    
DOI: 10.1097/YPG.0b013e328341a3c1     Document Type: Article

References (64)

1. Accortt EE, Freeman MP, Allen JJ (2008).Women and major depressive disorder: clinical perspectives on causal pathways. J Womens Health (Larchmt) 17:1583-1590.
2. Aklillu E, Karlsson S, Zachrisson OO, Ozdemir V, Agren H (2009). Association of MAOA gene functional promoter polymorphism with CSF dopamine turnover and atypical depression. Pharmacogenet Genomics 19:267-275.
3. Arias B, Serretti A, Lorenzi C, Gasto C, Catalan R, Fananas L (2006). Analysis of COMT gene (Val 158 Met polymorphism) in the clinical response to SSRIs in depressive patients of European origin. J Affect Disord 90:251-256.
4. Bailara KM, Henry C, Lestage J, Launay JM, Parrot F, Swendsen J, et al. (2006). Decreased brain tryptophan availability as a partial determinant of post-partum blues. Psychoneuroendocrinology 31:407-413.
5. Baune BT, Hohoff C, Mortensen LS, Deckert J, Arolt V, Domschke K (2008). Serotonin transporter polymorphism (5-HTTLPR) association with melancholic depression: A female specific effect? Depress Anxiety 25:920-925.
6. Bilder RM, Volavka J, Lachman HM, Grace AA (2004). The catechol-Omethyltransferase polymorphism: relations to the tonic-phasic dopamine hypothesis and neuropsychiatric phenotypes. Neuropsychopharmacology 29:1943-1961.
7. Bogen DL, Hanusa BH, Moses-Kolko E, Wisner KL (2010). Are maternal depression or symptom severity associated with breastfeeding intention or outcomes? J Clin Psychiatry 71:1069-1078.
8. Cahill L (2006). Why sex matters for neuroscience. Nat Rev Neurosci 7:477-484.
9. Caspi A, Moffitt TE (2006). Gene-environment interactions in psychiatry: joining forces with neuroscience. Nat Rev Neurosci 7:583-590.
10. Cervilla JA, Molina E, Rivera M, Torres-Gonzalez F, Bellon JA, Moreno B, et al. (2007). The risk for depression conferred by stressful life events is modified by variation at the serotonin transporter 5HTTLPR genotype: evidence from the Spanish PREDICT-Gene cohort. Mol Psychiatry 12:748-755.
11. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, et al. (2004). Functional analysis of genetic variation in catechol-O-methyltransferase (COMT): effects on mRNA, protein, and enzyme activity in postmortem human brain. Am J Hum Genet 75:807-821.
12. Cox JL, Holden JM, Sagovsky R (1987). Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale. Br J Psychiatry 150:782-786.
13. Cusin C, Serretti A, Lattuada E, Lilli R, Lorenzi C, Smeraldi E (2002). Association study of MAO-A, COMT, 5-HT2A, DRD2, and DRD4 polymorphisms with illness time course in mood disorders. Am J Med Genet 114:380-390.
14. Deckert J, Catalano M, Syagailo YV, Bosi M, Okladnova O, Di Bella D, et al. (1999). Excess of high activity monoamine oxidase A gene promoter alleles in female patients with panic disorder. Hum Mol Genet 8:621-624.
15. Doornbos B, Dijck-Brouwer DA, Kema IP, Tanke MA, van Goor SA, Muskiet FA, et al. (2009). The development of peripartum depressive symptoms is associated with gene polymorphisms of MAOA, 5-HTT and COMT. Prog Neuropsychopharmacol Biol Psychiatry 33:1250-1254. [Epub 2009 Jul 19]
16. DSM-IV-TR (2000). Diagnostic and statistical manual of mental disorders, fourth edition, text revision. Washington: American Psychiatric Association.
17. Ducci F, Goldman D (2008). Genetic approaches to addiction: genes and alcohol. Addiction 103:1414-1428.
18. Ducci F, Newman TK, Funt S, Brown GL, Virkkunen M, Goldman D (2006). A functional polymorphism in the MAOA gene promoter (MAOA-LPR) predicts central dopamine function and body mass index. Mol Psychiatry 11:858-866.
19. Enoch MA, Xu K, Ferro E, Harris CR, Goldman D (2003). Genetic origins of anxiety in women: A role for a functional catechol-O-methyltransferase polymorphism. Psychiatr Genet 13:33-41.
20. Funke B, Malhotra AK, Finn CT, Plocik AM, Lake SL, Lencz T, et al. (2005). COMT genetic variation confers risk for psychotic and affective disorders: A case control study. Behav Brain Funct 1:19.
21. Gaspar P, Cases O, Maroteaux L (2003). The developmental role of serotonin: news from mouse molecular genetics. Nat Rev Neurosci 4:1002-1012.
22. Gavin NI, Gaynes BN, Lohr KN, Meltzer-Brody S, Gartlehner G, Swinson T (2005). Perinatal depression: A systematic review of prevalence and incidence. Obstet Gynecol 106:1071-1083.
23. Gutierrez B, Bertranpetit J, Guillamat R, Valles V, Arranz MJ, Kerwin R, et al. (1997). Association analysis of the catechol-O-methyltransferase gene and bipolar affective disorder. Am J Psychiatry 154:113-115. (Pubitemid 27020204)
24. Gutierrez B, Arranz MJ, Collier DA, Valles V, Guillamat R, Bertranpetit J, et al. (1998). Serotonin transporter gene and risk for bipolar affective disorder: An association study in Spanish population. Biol Psychiatry 43:843-847.
25. Gutierrez B, Arias B, Gasto C, Catalan R, Papiol S, Pintor L, et al. (2004). Association analysis between a functional polymorphism in the monoamine oxidase A gene promoter and severe mood disorders. Psychiatr Genet 14:203-208.
26. Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, et al. (1996). Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621-2624.
27. Ip S, Chung M, Raman G, Chew P, Magula N, DeVine D, et al. (2007). Breastfeeding and maternal and infant health outcomes in developed countries. Evid Rep Technol Assess (Full Rep) 153:1-186.
28. Jabbi M, Korf J, Kema IP, Hartman C, van der Pompe G, Minderaa RB, et al. (2007). Convergent genetic modulation of the endocrine stress response involves polymorphic variations of 5-HTT, COMT and MAOA. Mol Psychiatry 12:483-490.
29. Jabbi M, Korf J, Ormel J, Kema IP, den Boer JA (2008). Investigating the molecular basis of major depressive disorder etiology: A functional convergent genetic approach. Ann N Y Acad Sci 1148:42-56.
30. Kaminsky Z, Wang SC, Petronis A (2006). Complex disease, gender and epigenetics. Ann Med 38:530-544.
31. Lachman HM, Kelsoe J, Moreno L, Katz S, Papolos DF (1997). Lack of association of catechol-O-methyltransferase (COMT) functional polymorphism in bipolar affective disorder. Psychiatr Genet 7:13-17.
32. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL, Weinshilboum RM (1996). Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 6:243-250.
33. Lesch KP, Gutknecht L (2005). Pharmacogenetics of the serotonin transporter. Prog Neuropsychopharmacol Biol Psychiatry 29:1062-1073.
34. Lin YM, Ko HC, Chang FM, Yeh TL, Sun HS (2009). Population-specific functional variant of the TPH2 gene 2755C> A polymorphism contributes risk association to major depression and anxiety in Chinese peripartum women. Arch Womens Ment Health 12:401-408. [Epub 2009 Jul 9]
35. Lundh W, Gyllang C (1993). Use of the Edinburgh Postnatal Depression Scale in some Swedish child health care centres. Scand J Caring Sci 7: 149-154.
36. Maes M, Ombelet W, Verkerk R, Bosmans E, Scharpe S (2001). Effects of pregnancy and delivery on the availability of plasma tryptophan to the brain: relationships to delivery-induced immune activation and early post-partum anxiety and depression. Psychol Med 31:847-858.
37. Massat I, Souery D, Del-Favero J, Nothen M, Blackwood D, Muir W, et al. (2005). Association between COMT (Val158Met) functional polymorphism and early onset in patients with major depressive disorder in a European multicenter genetic association study. Mol Psychiatry 10:598-605.
38. Moreno FA, Rowe DC, Kaiser B, Chase D, Michaels T, Gelernter J, et al. (2002). Association between a serotonin transporter promoter region polymorphism and mood response during tryptophan depletion. Mol Psychiatry 7:213-216.
39. Mynett-Johnson LA, Murphy VE, Claffey E, Shields DC, McKeon P (1998). Preliminary evidence of an association between bipolar disorder in females and the catechol-O-methyltransferase gene. Psychiatr Genet 8:221-225. (Pubitemid 28550213)
40. Newport DJ, Owens MJ, Knight DL, Ragan K, Morgan N, Nemeroff CB, et al. (2004). Alterations in platelet serotonin transporter binding in women with postpartum onset major depression. J Psychiatr Res 38:467-473.
41. Nonacs RM, Soares CN, Viguera AC, Pearson K, Poitras JR, Cohen LS (2005). Bupropion SR for the treatment of postpartum depression: A pilot study. Int J Neuropsychopharmacol 8:445-449.
42. Nordquist N, Oreland L (2010). Serotonin, genetic variability, behaviour, and psychiatric disorders - a review. Ups J Med Sci 115:2-10.
43. Nothen MM, Eggermann K, Albus M, Borrmann M, Rietschel M, Korner J, et al. (1995). Association analysis of the monoamine oxidase A gene in bipolar affective disorder by using family-based internal controls. Am J Hum Genet 57:975-978.
44. Papolos DF, Veit S, Faedda GL, Saito T, Lachman HM (1998). Ultra-ultra rapid cycling bipolar disorder is associated with the low activity catecholamine-Omethyltransferase allele. Mol Psychiatry 3:346-349.
45. Pechnick RN, Chesnokova V (2009). Adult neurogenesis, cell cycle and drug discovery in psychiatry. Neuropsychopharmacology 34:244.
46. Rivera M, Gutierrez B, Molina E, Torres-Gonzalez F, Bellon JA, Moreno-Kustner B, et al. (2009). High-activity variants of the uMAOA polymorphism increase the risk for depression in a large primary care sample. Am J Med Genet B Neuropsychiatr Genet 150B:395-402.
47. Robertson E, Grace S,Wallington T, Stewart DE (2004). Antenatal risk factors for postpartum depression: A synthesis of recent literature. Gen Hosp Psychiatry 26:289-295.
48. Rosengren A, Orth-Gomer K,Wedel H,Wilhelmsen L (1993). Stressful life events, social support, and mortality in men born in 1933. BMJ 307:1102-1105.
49. Rotondo A, Mazzanti C, Dell'Osso L, Rucci P, Sullivan P, Bouanani S, et al. (2002). Catechol-O-methyltransferase, serotonin transporter, and tryptophan hydroxylase gene polymorphisms in bipolar disorder patients with and without comorbid panic disorder. Am J Psychiatry 159:23-29.
50. Rubertsson C, Wickberg B, Gustavsson P, Radestad I (2005). Depressive symptoms in early pregnancy, two months and one year postpartumprevalence and psychosocial risk factors in a national Swedish sample. Arch Womens Ment Health 8:97-104.
51. Sabol SZ, Hu S, Hamer D (1998). A functional polymorphism in the monoamine oxidase A gene promoter. Hum Genet 103:273-279.
52. Sanjuan J, Martin-Santos R, Garcia-Esteve L, Carot JM, Guillamat R, Gutierrez-Zotes A, et al. (2008). Mood changes after delivery: role of the serotonin transporter gene. Br J Psychiatry 193:383-388.
53. Scanlon PD, Raymond FA, Weinshilboum RM (1979). Catechol-O- methyltransferase: Thermolabile enzyme in erythrocytes of subjects homozygous for allele for low activity. Science 203:63-65.
54. Schulze TG, Muller DJ, Krauss H, Scherk H, Ohlraun S, Syagailo YV, et al. (2000). Association between a functional polymorphism in the monoamine oxidase A gene promoter and major depressive disorder. Am J Med Genet 96:801-803.
55. Serretti A, Rotondo A, Lorenzi C, Smeraldi E, Cassano GB (2006). Catechol-Omethyltransferase gene variants in mood disorders in the Italian population. Psychiatr Genet 16:181-182.
56. Skalkidou A, Sylven SM, Papadopoulos FC, Olovsson M, Larsson A, Sundstrom-Poromaa I (2009). Risk of postpartum depression in association with serum leptin and interleukin-6 levels at delivery: A nested case-control study within the UPPSAT cohort. Psychoneuroendocrinology 34: 1329-1337. [Epub 2009 May 7]
57. Smolka MN, Buhler M, Schumann G, Klein S, Hu XZ, Moayer M, et al. (2007). Gene-gene effects on central processing of aversive stimuli. Mol Psychiatry 12:307-317.
58. Sun HS, Tsai HW, Ko HC, Chang FM, Yeh TL (2004). Association of tryptophan hydroxylase gene polymorphism with depression, anxiety and comorbid depression and anxiety in a population-based sample of postpartum Taiwanese women. Genes Brain Behav 3:328-336.
59. Szegedi A, Rujescu D, Tadic A, Muller MJ, Kohnen R, Stassen HH, et al. (2005). The catechol-O-methyltransferase Val108/158Met polymorphism affects short-term treatment response to mirtazapine, but not to paroxetine in major depression. Pharmacogenomics J 5:49-53.
60. Wickberg B, Hwang CP (1996). The Edinburgh Postnatal Depression Scale: validation on a Swedish community sample. Acta Psychiatr Scand 94:181-184.
61. Willeit M, Praschak-Rieder N, Neumeister A, Zill P, Leisch F, Stastny J, et al. (2003). A polymorphism (5-HTTLPR) in the serotonin transporter promoter gene is associated with DSM-IV depression subtypes in seasonal affective disorder. Mol Psychiatry 8:942-946.
62. Wisner KL, Perel JM, Peindl KS, Hanusa BH, Piontek CM, Findling RL (2004). Prevention of postpartum depression: A pilot randomized clinical trial. Am J Psychiatry 161:1290-1292.
63. Wray NR, James MR, Gordon SD, Dumenil T, Ryan L, Coventry WL, et al. (2009). Accurate, large-scale genotyping of 5HTTLPR and flanking single nucleotide polymorphisms in an association study of depression, anxiety, and personality measures. Biol Psychiatry 66:468-476. [Epub 2009 Jun 21]
64. Zonana J, Gorman JM (2005). The neurobiology of postpartum depression. CNS Spectr 10:792-799. 805.